News
Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market share
Novo’s shares have plunged since hitting a record-high in June last year as competition, particularly from Eli Lilly, makes inroads into its market share and as its pipeline of new drugs has ...
Novo's shares have plunged since hitting a record-high in June last year as competition, particularly from U.S. rival Eli ...
Novo Nordisk announced on Friday morning that its CEO Lars Fruergaard Jørgensen is stepping down after leading the company for eight years. In a release announcing the decision, the Danish pharma ...
54m
Al Jazeera on MSNIn surprise move Wegovy-maker Novo Nordisk ousts CEO amid sagging salesDays earlier, Novo Nordisk cut its sales and profit forecast for first time since the launch of Wegovy four years ago.
Jørgensen has agreed to stay on while the search for a successor is carried out, and the chair of the Novo Nordisk Foundation ...
Novo Nordisk announces CEO transition as Lars Fruergaard Jørgensen departs amid Wegovy market share losses to Zepbound and ongoing supply chain disruptions ...
US stocks were little changed on Friday, poised for weekly wins after an easing in US-China trade tensions. Investors also ...
Futures on Wall Street are trading with gains indicating a positive start for Wall Street on the final trading day of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results